Daiwa Securities Group
XBIT icon

Daiwa Securities Group’s XBiotech XBIT Stock Holding History

Daiwa Securities Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-64
Closed -$1K – 1453
2021
Q3 		$1K Hold
64
– – ﹤0.01% 1289
2021
Q2 		$1K Hold
64
– – ﹤0.01% 1221
2021
Q1 		$1K Hold
64
– – ﹤0.01% 1233
2020
Q4 		$1K Sell
64
-100
-61% -$1.84K ﹤0.01% 1212
2020
Q3 		$3K Sell
164
-72
-31% -$1.24K ﹤0.01% 1121
2020
Q2 		$3K Hold
236
– – ﹤0.01% 1145
2020
Q1 		$3K Buy
236
+4
+2% +$65 ﹤0.01% 1144
2019
Q4 		$4K Buy
+232
New +$2.99K ﹤0.01% 1134

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Daiwa Securities Group's XBIT Position: Q4 2021 in Review

Daiwa Securities Group sold out of XBiotech (XBIT) in Q4 2021, closing a stake of 64 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in XBIT in Q4 2019 and held it in 8 quarters. The position peaked at $4K in Q4 2019. 61 funds tracked by Wall St. Rank hold XBIT as of Q4 2021.

  • Daiwa Securities Group reported no remaining XBiotech position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 64 XBiotech shares in Q4 2021, an estimated $1K.
  • Daiwa Securities Group first reported a position in XBiotech in Q4 2019 and held it in 8 quarters.
  • Daiwa Securities Group's XBiotech position peaked at $4K in Q4 2019.
  • 61 funds tracked by Wall St. Rank held XBiotech as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.